Orfadin & Succinylacetone increased

21.7%

of users reported Succinylacetone increased

74.5%

also reported Severe reaction

51.7%

are men

Severe reaction

74.5%

Disability

11.8%

Hospitalization

9.8%

Death

2.0%

Life-threatening condition

2.0%

Orfadin: general information

0 - 9 years

53.4%

10 - 19 years

35.9%

20 - 29 years

5.8%

30 - 39 years

<0.1%

40 - 49 years

<0.1%

50 - 59 years

4.9%